×
S&P 500   3,885.28 (+1.05%)
DOW   31,291.83 (+0.82%)
QQQ   289.71 (+0.32%)
AAPL   143.12 (+0.14%)
MSFT   265.40 (-0.30%)
META   170.00 (+0.14%)
GOOGL   2,305.71 (+0.62%)
AMZN   114.08 (-0.22%)
TSLA   700.53 (+0.77%)
NVDA   154.99 (+2.44%)
NIO   21.33 (+2.40%)
BABA   120.87 (+1.47%)
AMD   77.11 (+2.34%)
MU   58.55 (+2.06%)
T   21.17 (+0.38%)
F   11.27 (+1.90%)
DIS   96.85 (+0.80%)
AMC   12.62 (+0.40%)
PFE   52.81 (+0.11%)
PYPL   73.31 (+0.10%)
NFLX   184.70 (+0.35%)
S&P 500   3,885.28 (+1.05%)
DOW   31,291.83 (+0.82%)
QQQ   289.71 (+0.32%)
AAPL   143.12 (+0.14%)
MSFT   265.40 (-0.30%)
META   170.00 (+0.14%)
GOOGL   2,305.71 (+0.62%)
AMZN   114.08 (-0.22%)
TSLA   700.53 (+0.77%)
NVDA   154.99 (+2.44%)
NIO   21.33 (+2.40%)
BABA   120.87 (+1.47%)
AMD   77.11 (+2.34%)
MU   58.55 (+2.06%)
T   21.17 (+0.38%)
F   11.27 (+1.90%)
DIS   96.85 (+0.80%)
AMC   12.62 (+0.40%)
PFE   52.81 (+0.11%)
PYPL   73.31 (+0.10%)
NFLX   184.70 (+0.35%)
S&P 500   3,885.28 (+1.05%)
DOW   31,291.83 (+0.82%)
QQQ   289.71 (+0.32%)
AAPL   143.12 (+0.14%)
MSFT   265.40 (-0.30%)
META   170.00 (+0.14%)
GOOGL   2,305.71 (+0.62%)
AMZN   114.08 (-0.22%)
TSLA   700.53 (+0.77%)
NVDA   154.99 (+2.44%)
NIO   21.33 (+2.40%)
BABA   120.87 (+1.47%)
AMD   77.11 (+2.34%)
MU   58.55 (+2.06%)
T   21.17 (+0.38%)
F   11.27 (+1.90%)
DIS   96.85 (+0.80%)
AMC   12.62 (+0.40%)
PFE   52.81 (+0.11%)
PYPL   73.31 (+0.10%)
NFLX   184.70 (+0.35%)
S&P 500   3,885.28 (+1.05%)
DOW   31,291.83 (+0.82%)
QQQ   289.71 (+0.32%)
AAPL   143.12 (+0.14%)
MSFT   265.40 (-0.30%)
META   170.00 (+0.14%)
GOOGL   2,305.71 (+0.62%)
AMZN   114.08 (-0.22%)
TSLA   700.53 (+0.77%)
NVDA   154.99 (+2.44%)
NIO   21.33 (+2.40%)
BABA   120.87 (+1.47%)
AMD   77.11 (+2.34%)
MU   58.55 (+2.06%)
T   21.17 (+0.38%)
F   11.27 (+1.90%)
DIS   96.85 (+0.80%)
AMC   12.62 (+0.40%)
PFE   52.81 (+0.11%)
PYPL   73.31 (+0.10%)
NFLX   184.70 (+0.35%)
CVE:HTL

Hamilton Thorne Stock Forecast, Price & News

C$1.51
-0.06 (-3.82%)
(As of 07/6/2022 03:05 PM ET)
Add
Compare
Today's Range
C$1.51
C$1.55
50-Day Range
C$1.35
C$1.73
52-Week Range
C$1.31
C$2.20
Volume
43,390 shs
Average Volume
67,094 shs
Market Capitalization
C$216.22 million
P/E Ratio
75.50
Dividend Yield
N/A
Price Target
C$2.33

Hamilton Thorne MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
54.0% Upside
C$2.33 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
C$23,994 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.68 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive HTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hamilton Thorne and its competitors with MarketBeat's FREE daily newsletter.

Hamilton Thorne logo

About Hamilton Thorne (CVE:HTL) Stock

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets under the Hamilton Thorne brand; test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services under the Embryotech brand. The company also manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics under the Gynemed brand; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand. It sells its products and services through a direct sales force in the United States, Germany, France, and the United Kingdom, as well as through distributors to approximately 2,000 fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.

HTL Stock News Headlines

Hamilton Thorne (CVE:HTL) Trading Down 1.9%
CORRECTING and REPLACING - Hamilton Thorne Ltd.
Hamilton Thorne Appoints Feng Han to Board of Directors
Hamilton Thorne Appoints Marc Robinson to Board of Directors
TSXV:HTL (HAMILTON THORNE LTD)
Hamilton Thorne Ltd.
Hamilton Thorne Announces Full Conversion of Outstanding Debentures
See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Company Calendar

Today
7/07/2022
Next Earnings (Estimated)
8/17/2022

Price Target and Rating

Average Stock Price Forecast
C$2.33
High Stock Price Forecast
C$2.40
Low Stock Price Forecast
C$2.25
Forecasted Upside/Downside
+54.0%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
2 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$54.89 million
Cash Flow
C$0.11 per share
Book Value
C$0.39 per share

Miscellaneous

Free Float
N/A
Market Cap
C$216.22 million
Optionable
Not Optionable
Beta
N/A














Hamilton Thorne Frequently Asked Questions

Should I buy or sell Hamilton Thorne stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Hamilton Thorne stock.
View analyst ratings for Hamilton Thorne
or view top-rated stocks.

What is Hamilton Thorne's stock price forecast for 2022?

2 brokerages have issued 12-month price targets for Hamilton Thorne's shares. Their HTL stock forecasts range from C$2.25 to C$2.40. On average, they anticipate Hamilton Thorne's stock price to reach C$2.33 in the next twelve months. This suggests a possible upside of 54.0% from the stock's current price.
View analysts' price targets for Hamilton Thorne
or view top-rated stocks among Wall Street analysts.

How has Hamilton Thorne's stock price performed in 2022?

Hamilton Thorne's stock was trading at C$2.06 at the beginning of the year. Since then, HTL shares have decreased by 26.7% and is now trading at C$1.51.
View the best growth stocks for 2022 here
.

When is Hamilton Thorne's next earnings date?

Hamilton Thorne is scheduled to release its next quarterly earnings announcement on Wednesday, August 17th 2022.
View our earnings forecast for Hamilton Thorne
.

Who are Hamilton Thorne's key executives?

Hamilton Thorne's management team includes the following people:
  • Mr. David B. Wolf, Chair, Pres, & CEO
  • Mr. Diarmaid H. Douglas-Hamilton, Co-Founder, Sr. VP of R&D, CTO and Corp. Sec.
  • Ms. Meg Spencer, Co-Founder & Director
  • Mr. Michael W. Bruns, VP of Fin. & CFO (Age 65, Pay $282.68k)
  • Mr. Brett M. Fulton, Sr. VP & GM
  • Justin Jaundoo, VP of Corp. Devel.
  • Mr. Eric V. Dorman, Pres of Embryotech Laboratories Inc
  • Dr. Fabian Sell, Chief Exec. Officer of Gynemed
  • Joel Lopez, Pres of Embryotech Laboratories

What other stocks do shareholders of Hamilton Thorne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hamilton Thorne investors own include Trican Well Service (TCW), mdf commerce (MDF), Micron Technology (MU), LHC Group (LHCG), Mainstreet Equity (MEQ), Materialise (MTLS), AltaGas (ALA), (ALYA), Bank of America (BAC) and British American Tobacco (BATS).

What is Hamilton Thorne's stock symbol?

Hamilton Thorne trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HTL."

How do I buy shares of Hamilton Thorne?

Shares of HTL and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Hamilton Thorne's stock price today?

One share of HTL stock can currently be purchased for approximately C$1.51.

How much money does Hamilton Thorne make?

Hamilton Thorne (CVE:HTL) has a market capitalization of C$216.22 million and generates C$54.89 million in revenue each year.

How can I contact Hamilton Thorne?

Hamilton Thorne's mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The official website for Hamilton Thorne is www.hamiltonthorne.com. The company can be reached via phone at +1-978-9212050.

This page (CVE:HTL) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.